Sep 26 |
Acurx Announces Additional Ibezapolstat Ph2b Results in CDI as well as Anthrax (B. anthracis) Susceptibility to ACX-375 Analogues
|
Sep 24 |
Acurx Announces Results of Its Pioneering Research with Ibezapolstat in Collaboration with Leiden University Medical Center at the Premier International C. difficile Symposium
|
Sep 9 |
New to the Street Announces Its Five Corporate Interviews, Airing Episode 599 on the Fox Business Network, Tonight Monday, September 9, 2024, at 10:30 PM PT September 9, 2024 09:15 ET
|
Aug 26 |
ACURX PHARMACEUTICALS ANNOUNCES PARTICIPATION AT THE H.C. Wainwright 26th Annual Global Investment Conference
|
Aug 25 |
We're A Little Worried About Acurx Pharmaceuticals' (NASDAQ:ACXP) Cash Burn Rate
|
Aug 19 |
New to The Street Announces Episode 590, Five Corporate Interviews, Airing on the Fox Business Network, Tonight Monday, August 19, 2024, at 10:30 PM PT
|
Aug 9 |
Acurx Pharmaceuticals, Inc. (ACXP) Q2 2024 Earnings Call Transcript
|
Aug 9 |
New to The Street TV Announces Episode 583, Five Riveting Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Saturday, August 10, 2024, at 6:30 PM ET
|
Aug 9 |
Acurx Pharmaceuticals GAAP EPS of -$0.26 misses by $0.04
|
Aug 9 |
Acurx Pharmaceuticals, Inc. Reports Second Quarter 2024 Results and Provides Business Update
|